![Robert John](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert John
Corporate Officer/Principal presso
CVRX, INC.
Patrimonio netto: 54 662 $ in data 31/05/2026
Profilo
Robert John is currently Chief Revenue Officer at CVRx, Inc. since 2024.
Formerly, Mr. John was General Manager-Cardiac Rhythm Management EMEA at Abbott Laboratories from 2008 to 2023.
Education includes graduate studies at The University of Alabama and undergraduate studies at the University of North Texas.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CVRX, INC. 0,04% | 06/04/2026 | 9.796 ( 0,04% ) | 54 662 $ | 31/05/2026 |
Posizioni attive di Robert John
| Società | Posizione | Inizio |
|---|---|---|
| CVRX, INC. | Corporate Officer/Principal | 27/06/2024 |
Precedenti posizioni note di Robert John
| Società | Posizione | Fine |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2023 |
Formazione di Robert John
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
73
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
The University of Alabama
 The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of North Texas
 University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CVRx, Inc.
 CVRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes neuromodulation device & implantable technology to treat hypertension and heart failure | Health Technology |
